Cargando…
Risk of Bias in Systematic Reviews of Non-Randomized Studies of Adverse Cardiovascular Effects of Thiazolidinediones and Cyclooxygenase-2 Inhibitors: Application of a New Cochrane Risk of Bias Tool
BACKGROUND: Systematic reviews of the effects of healthcare interventions frequently include non-randomized studies. These are subject to confounding and a range of other biases that are seldom considered in detail when synthesizing and interpreting the results. Our aims were to assess the reliabili...
Autores principales: | Bilandzic, Anja, Fitzpatrick, Tiffany, Rosella, Laura, Henry, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4821619/ https://www.ncbi.nlm.nih.gov/pubmed/27046153 http://dx.doi.org/10.1371/journal.pmed.1001987 |
Ejemplares similares
-
The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials
por: Higgins, Julian P T, et al.
Publicado: (2011) -
Most Cochrane systematic reviews and protocols did not adhere to the Cochrane's risk of bias 2.0 tool
por: Martimbianco, Ana Luiza Cabrera, et al.
Publicado: (2023) -
Evaluation of the Cochrane tool for assessing risk of bias in randomized clinical trials: overview of published comments and analysis of user practice in Cochrane and non-Cochrane reviews
por: Jørgensen, Lars, et al.
Publicado: (2016) -
Recommendations by Cochrane Review Groups for assessment of the risk of bias in studies
por: Lundh, Andreas, et al.
Publicado: (2008) -
Considerations from the risk of bias perspective for updating Cochrane reviews
por: Mayhew, Alain D., et al.
Publicado: (2015)